Dixon J S, Bird H A, Sitton N G, Pickup M E, Leatham P A, Wright V
Agents Actions. 1983 Jun;13(4):373-9. doi: 10.1007/BF01971492.
In a long-term study we have been comparing biochemical changes in the blood of patients with classical or definite rheumatoid arthritis (RA) when groups of patients are treated for the first time with specific anti-rheumatoid drugs for a six-month period. One such group was treated for 26 weeks with azathioprine. Biochemical and clinical assessments were made at each of 10 clinic visits during the treatment period. Side-effects prevented six patients completing the study. Clinical improvement in the remaining patients was accompanied by a reduction in acute phase proteins, increases in total serum sulphydryl and serum histidine, but little or no change in immunological variables. Comparison of correlation matrices constructed between clinical and laboratory variables for azathioprine and drugs previously tested suggests that azathioprine is more effective than a control group on aspirin alone and in some ways comparable with D-penicillamine.
在一项长期研究中,我们一直在比较经典型或确诊类风湿性关节炎(RA)患者首次使用特定抗风湿药物治疗六个月期间血液中的生化变化。其中一组患者用硫唑嘌呤治疗了26周。在治疗期间的10次门诊就诊时均进行了生化和临床评估。副作用导致6名患者未能完成研究。其余患者的临床改善伴随着急性期蛋白的减少、血清总巯基和血清组氨酸的增加,但免疫变量几乎没有变化。对硫唑嘌呤与先前测试药物的临床和实验室变量之间构建的相关矩阵进行比较表明,硫唑嘌呤比仅使用阿司匹林的对照组更有效,并且在某些方面与青霉胺相当。